Techno Medical Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Techno Medical heeft een totaal eigen vermogen van THB423.7M en een totale schuld van THB403.4M, wat de schuld-eigenvermogensverhouding op 95.2% brengt. De totale activa en totale passiva bedragen respectievelijk THB928.3M en THB504.6M.

Belangrijke informatie

95.2%

Verhouding schuld/eigen vermogen

฿403.38m

Schuld

Rente dekkingsratio	n/a
Contant	฿81.37m
Aandelen	฿423.66m
Totaal verplichtingen	฿504.60m
Totaal activa	฿928.25m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( THB510.2M ) TM } overtreffen de korte termijn passiva ( THB379.3M ).

Langlopende schulden: De kortetermijnactiva TM ( THB510.2M ) overtreffen de langetermijnschulden ( THB125.3M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 76% ) TM wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van TM is de afgelopen 5 jaar gestegen van 35.7% naar 95.2%.

Schuldendekking: De schuld van TM wordt niet goed gedekt door de operationele kasstroom ( 1.3% ).

Rentedekking: Er zijn onvoldoende gegevens om te bepalen of de rentebetalingen van TM op haar schulden goed worden gedekt door EBIT.

Techno Medical Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

New major risk - Dividend sustainability

Second quarter 2024 earnings released: ฿0.023 loss per share (vs ฿0.002 profit in 2Q 2023)

First quarter 2024 earnings released: ฿0.019 loss per share (vs ฿0.016 profit in 1Q 2023)

Techno Medical Public Company Limited Approves Cash Dividend for the Year Ended December 31, 2023, Payable on May 15, 2024

Upcoming dividend of ฿0.033 per share

Dividend reduced to ฿0.033

Techno Medical Public Company Limited Announces Cash Dividend for 2023, Payable on May 15, 2024

Full year 2023 earnings released: ฿0.015 loss per share (vs ฿0.042 profit in FY 2022)

Techno Medical Public Company Limited, Annual General Meeting, Apr 19, 2024

Third quarter 2023 earnings released: ฿0.025 loss per share (vs ฿0.005 loss in 3Q 2022)

Second quarter 2023 earnings released: EPS: ฿0.002 (vs ฿0.013 in 2Q 2022)

First quarter 2023 earnings released: EPS: ฿0.016 (vs ฿0.019 in 1Q 2022)

Upcoming dividend of ฿0.05 per share at 2.0% yield

Full year 2022 earnings released: EPS: ฿0.042 (vs ฿0.097 in FY 2021)

Third quarter 2022 earnings released: ฿0.005 loss per share (vs ฿0.078 profit in 3Q 2021)

Less than half of directors are independent

Second quarter 2022 earnings released: EPS: ฿0.013 (vs ฿0.003 loss in 2Q 2021)

First quarter 2022 earnings released: EPS: ฿0.019 (vs ฿0.002 in 1Q 2021)

Less than half of directors are independent

Techno Medical Public Company Limited Approves Cash Dividend for the Year Ended December 31, 2021, Payable on May 17, 2022

Upcoming dividend of ฿0.085 per share

Techno Medical Public Company Limited Proposes Cash Dividend Payment for the Year 2021, Payable on April 26, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS ฿0.078 (vs ฿0.039 in 3Q 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: ฿0.003 loss per share (vs ฿0.019 profit in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

First quarter 2021 earnings released: EPS ฿0.001 (vs ฿0.041 in 1Q 2020)

Upcoming dividend of ฿0.10 per share

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS ฿0.13 (vs ฿0.20 in FY 2019)

New 90-day high: ฿2.46

New 90-day high: ฿2.42

New 90-day low: ฿2.24

New 90-day low - ฿2.28

Earnings released

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven